Stocks · News reference

Needham Initiates Coverage of Clover Health Investments with Buy Rating

Oct 28, 2026, 1:32 PM

Needham & Company has initiated research coverage on Clover Health Investments, Corp. with a 'Buy' rating and a price target of $6.00.

More stocks news Connected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source: fiscal.ai
Observed: Oct 28, 2026, 1:32 PM
Checked: Oct 28, 2026, 1:33 PM
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

Fiscal.aiOct 26, 2026, 10:02 PM
Clover Health to Participate in Upcoming UBS Global Healthcare Conference
Clover Health Investments, Corp. announced that its Interim Chief Financial Officer, Clay Thornton, will present at the 2026 UBS Global Healthcare Conference on November 9, 2026.
CLOV
BenzingaOct 13, 2026, 7:39 PMErica Kollmann
QUICK SPARK: UnitedHealth Calls 2026 the Bottom for Medicaid Margins
UnitedHealth expects Medicaid margins to bottom in 2026 and improve through 2028, UnitedHealthcare CEO Tim Noel says on earnings call.
CLOV CVS HUM UNH
BenzingaOct 9, 2026, 6:42 PMBenzinga Newsdesk
Shares of health insurance companies are trading higher the U.S. CMS awarded five- and four-star ratings to plans offered by UnitedHealth Group, Clover, and Humana among others. Also, Humana reaffirmed its FY26 adjusted EPS guidance and issued optimistic comments about FY27 and FY28.
CLOV CNC ELV UNH